Tina Schmidt
Acute Care · Sellersville, PANPI 1316198385
Payments from drug & device makers
Across 86 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$477
- AstraZeneca$210
- EMD Serono, Inc.$128
- Daiichi Sankyo Inc.$89
- GSK$86
- Bristol Myers Squibb$79
- plus $894 from 30 others
What the payments were for
- Food & beverage$1,80692%
- Education$1126%
- Other$442%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 23 | $477 |
| AstraZeneca(2 entities) | 6 | $210 |
| EMD Serono, Inc. | 5 | $128 |
| Daiichi Sankyo Inc. | 4 | $89 |
| GSK | 4 | $86 |
| Bristol Myers Squibb | 3 | $79 |
| Incyte Corporation | 4 | $77 |
| AbbVie | 2 | $56 |
| Johnson & Johnson(2 entities) | 3 | $55 |
| Astellas Pharma US Inc | 2 | $51 |
| Welch Allyn | 1 | $44 |
| Tempus AI, Inc | 2 | $44 |
| Sobi, Inc | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Amgen | 2 | $35 |
| Pfizer | 1 | $35 |
| Pharmacosmos Therapeutics Inc. | 1 | $34 |
| Legend Biotech USA Inc. | 1 | $27 |
| Gilead | 1 | $26 |
| Bayer | 1 | $26 |
| Acrotech Biopharma Inc. | 1 | $25 |
| AVEO Pharmaceuticals, Inc. | 1 | $23 |
| Karyopharm Therapeutics Inc. | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Seagen Inc. | 1 | $21 |
| Morphosys, US Inc. | 1 | $21 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $13 |
| Myovant Sciences Inc. | 1 | $13 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $12 |
How this compares
$1,962 in reported general payments places this provider in the 85th percentile of 872 acute care providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Sellersville
- Kristi MontrellaAltoona$111K
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Donna KinzlerPittsburgh$25K
- Lisa JohnsonPottstown$25K
- Kathryn McParlaneMoon Township$21K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
- Kevin HaganAbington$17K
- Rachel ChristyButler$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.